Topiramate in traumatic brain injury: Adverse effects on cognitive function

Journal of Head Trauma Rehabilitation

Volumn 22, Issue 6, 2007, Pages 409-410

  Tang, Vivien ^a   Warden, Julia ^b   Cullen, Nora ^b,c   Rutledge, Eleanor ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO REHABILITATION INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TOPIRAMATE; VOLTAGE GATED SODIUM CHANNEL;

AGGRESSION; AGGRESSIVENESS; ALERTNESS; ANTHROPOMETRIC PARAMETERS; ANXIETY DISORDER; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; COGNITION; COGNITIVE DEFECT; CONFUSION; DEPERSONALIZATION; DEREALIZATION; DEVELOPMENTAL DISORDER; DISORGANIZED THOUGHT PROCESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EPILEPSY; FLATTENED AFFECT; HUMAN; LANGUAGE DISABILITY; LOW DRUG DOSE; MENTAL DEFICIENCY; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; RESTLESSNESS; SEIZURE; SHORT SURVEY; SIDE EFFECT; SLOWING OF THINKING; TRAUMATIC BRAIN INJURY; VERBAL FLUENCY; VISUAL HALLUCINATION; WORD FINDING DIFFICULTY; WORKING MEMORY;

BRAIN INJURIES; COGNITION; FRUCTOSE; HUMANS; LANGUAGE DISORDERS; MENTAL DISORDERS; NEUROPROTECTIVE AGENTS;

EID: 36348971720     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HTR.0000300236.21114.bc     Document Type: Short Survey

References (19)

1. Gross-Tsur V, Shalev RS. Reversible language regression as an adverse effect of topiramate treatment in children. Neurology. 2004;62:299-300.
2. Jansen J, Aldenkamp AP, Majoie H, et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav. 2006;9:181-185.
3. Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 2005;6:373-381.
4. Antai-Otong D. Mitigating cognitive side effects associated with topiramate. Perspect Psychiatr Care. 2005;41:92-93.
5. SmithME, Gevins A,McEvoy LK,Meador KJ, Ray PG, Gilliam F. Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate. Epilepsia. 2006;47:695-703.
6. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA. 2004;291:605-614.
7. Huber B. Effects of topiramate in patients with epilepsy and intellectual deficits. Nervenarzt. 2002;73:525-532.
8. Kerr MP, Baker GA, Brodie MJ. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity and quality of life. Epilepsy Behav. 2005;7:472-480.
9. Singh BK, White-Scott S. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Seizure. 2002;11:47-50.
10. Mula M, Trimble MR, Thompson P, Sander J. Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003;60:1104-1107.
11. Lee HW, Jung DK, Suh CK, Kwon SH, Park SP. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up. Epilepsy Behav. 2006;8:736-741.
12. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia. 2003;44:339-347.
13. Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res. 2003;54:171-178.
14. Rorsman I, Kallen K. Recovery of cognitive and emotional functioning following withdrawal of topiramate maintenance therapy. Seizure. 2001;10:592-595.
15. Stella F, Caetano D,Cendes F, Guerreiro C. Acute psychotic disorders induced by topiramate. ArqNeuropsiquiatr. 2002;60:285-287.
16. Khan A, Faught E, Gilliam F, Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure. 1999;8:235-237.
17. Kober D, Gabbard GO. Topiramate-induced psychosis. Am J Psychiatry. 2005;162:8.
18. Mula M, Trimble MR, Lhatoo SD, Sander J. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003;44:659-663.
19. Schlatter FJ, Soutullo CA, Cervera-Enguix S. First break of mania associated with topiramate treatment. J Clin Psychopharmacol. 2001;21:464-466.